Heritable Susceptibility to Breast Cancer among African-American Women in the Detroit Research on Cancer Survivors Study.

IF 3.7 3区 医学 Q2 ONCOLOGY
Kristen S Purrington, Sreejata Raychaudhuri, Michael S Simon, Julie Clark, Valerie Ratliff, Gregory Dyson, Douglas B Craig, Julie L Boerner, Jennifer L Beebe-Dimmer, Ann G Schwartz
{"title":"Heritable Susceptibility to Breast Cancer among African-American Women in the Detroit Research on Cancer Survivors Study.","authors":"Kristen S Purrington, Sreejata Raychaudhuri, Michael S Simon, Julie Clark, Valerie Ratliff, Gregory Dyson, Douglas B Craig, Julie L Boerner, Jennifer L Beebe-Dimmer, Ann G Schwartz","doi":"10.1158/1055-9965.EPI-20-0564","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>African-American women have high rates of breast cancer associated with hereditary features. However, no studies have reported the prevalence of inherited variation across all genes known to be breast cancer risk factors among African-American patients with breast cancer not selected for high-risk characteristics.</p><p><strong>Methods: </strong>We evaluated 182 African-American women diagnosed with invasive breast cancer in metropolitan Detroit via targeted capture and multiplex sequencing of 13 well-established breast cancer risk genes and five suggested breast cancer risk genes.</p><p><strong>Results: </strong>We identified 24 pathogenic variants in 23 women [12.6%; 95% confidence interval (CI), 8.2%-18.4%] and five genes (<i>BRCA2, BRCA1, ATM, RAD50, CDH1</i>). <i>BRCA1</i> and <i>BRCA2</i> accounted for 58.3% of all pathogenic variants. An additional six pathogenic variants were found in suggested breast cancer risk genes (<i>MSH6, MUTYH, NF1, BRIP1</i>).</p><p><strong>Conclusions: </strong>The prevalence of germline pathogenic variants is relatively high among African-American patients with breast cancer unselected for high-risk characteristics across a broad spectrum of genes.</p><p><strong>Impact: </strong>This study helps to define the genomic landscape of breast cancer susceptibility in African-American women who could benefit from enhanced surveillance and screening.</p>","PeriodicalId":9458,"journal":{"name":"Cancer Epidemiology Biomarkers & Prevention","volume":"29 11","pages":"2369-2375"},"PeriodicalIF":3.7000,"publicationDate":"2020-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7642006/pdf/nihms-1625708.pdf","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Epidemiology Biomarkers & Prevention","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1158/1055-9965.EPI-20-0564","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2020/8/31 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Background: African-American women have high rates of breast cancer associated with hereditary features. However, no studies have reported the prevalence of inherited variation across all genes known to be breast cancer risk factors among African-American patients with breast cancer not selected for high-risk characteristics.

Methods: We evaluated 182 African-American women diagnosed with invasive breast cancer in metropolitan Detroit via targeted capture and multiplex sequencing of 13 well-established breast cancer risk genes and five suggested breast cancer risk genes.

Results: We identified 24 pathogenic variants in 23 women [12.6%; 95% confidence interval (CI), 8.2%-18.4%] and five genes (BRCA2, BRCA1, ATM, RAD50, CDH1). BRCA1 and BRCA2 accounted for 58.3% of all pathogenic variants. An additional six pathogenic variants were found in suggested breast cancer risk genes (MSH6, MUTYH, NF1, BRIP1).

Conclusions: The prevalence of germline pathogenic variants is relatively high among African-American patients with breast cancer unselected for high-risk characteristics across a broad spectrum of genes.

Impact: This study helps to define the genomic landscape of breast cancer susceptibility in African-American women who could benefit from enhanced surveillance and screening.

底特律癌症幸存者研究》中非裔美国妇女对乳腺癌的遗传易感性。
背景:非裔美国妇女患乳腺癌的高发与遗传特征有关。然而,还没有研究报告过所有已知为乳腺癌风险因素的基因在非裔美国人乳腺癌患者中的遗传变异发生率:我们对底特律大都会地区确诊为浸润性乳腺癌的 182 名非裔美国妇女进行了评估,对 13 个公认的乳腺癌风险基因和 5 个建议的乳腺癌风险基因进行了靶向捕获和多重测序:我们在 23 名女性[12.6%;95% 置信区间 (CI),8.2%-18.4%]和五个基因(BRCA2、BRCA1、ATM、RAD50、CDH1)中发现了 24 个致病变体。BRCA1 和 BRCA2 占所有致病变异的 58.3%。在建议的乳腺癌风险基因(MSH6、MUTYH、NF1、BRIP1)中还发现了另外六个致病变异:结论:在非裔美国人乳腺癌患者中,种系致病性变异的发生率相对较高,这些变异涉及广泛的高风险基因:这项研究有助于确定非裔美国妇女乳腺癌易感性的基因组状况,加强监测和筛查可使这些妇女受益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Cancer Epidemiology Biomarkers & Prevention
Cancer Epidemiology Biomarkers & Prevention 医学-公共卫生、环境卫生与职业卫生
CiteScore
6.50
自引率
2.60%
发文量
538
审稿时长
1.6 months
期刊介绍: Cancer Epidemiology, Biomarkers & Prevention publishes original peer-reviewed, population-based research on cancer etiology, prevention, surveillance, and survivorship. The following topics are of special interest: descriptive, analytical, and molecular epidemiology; biomarkers including assay development, validation, and application; chemoprevention and other types of prevention research in the context of descriptive and observational studies; the role of behavioral factors in cancer etiology and prevention; survivorship studies; risk factors; implementation science and cancer care delivery; and the science of cancer health disparities. Besides welcoming manuscripts that address individual subjects in any of the relevant disciplines, CEBP editors encourage the submission of manuscripts with a transdisciplinary approach.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信